Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Respiration Disorders × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Neoplasms 28 Lung Neoplasms 22 Colorectal Neoplasms 20 Uterine Cervical Neoplasms 11 Prostatic Neoplasms 11 Motor Activity 10 Colonic Neoplasms 9 Anxiety Disorders 8 Rectal Neoplasms 7 Pancreatic Neoplasms 7 Obesity 7 Carcinoma, Non-Small-Cell Lung 7 Lymphoma 6 Depression 6 Breast Carcinoma In Situ 6 Hematologic Neoplasms 5 Endometrial Neoplasms 5 Vulvar Neoplasms 4 Urinary Bladder Neoplasms 4 Pain 4 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Head and Neck Neoplasms 4 Fatigue 4 Vaginal Neoplasms 3 Triple Negative Breast Neoplasms 3 Testicular Neoplasms 3 Stomach Neoplasms 3

Interventions

Propofol 1 Midazolam 1 Methods 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03750110 2022-05-19

YESS

University of Nottingham

Phase NA Completed

Heart Diseases, Lung Neoplasms, Respiration Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡